au-tgaMedicines Safet...
Extension of substitution approval for shortage of Catapres (clonidine) 150 mcg tablets
Published: April 27, 2026Recall ID: 558979Category: drugsCountry: Australia
Pharmaceutical
Australia
Extension of substitution approval for shortage of Catapres (clonidine) 150 mcg tablets
Recalling Firm: TGA
Reason for Recall / Hazard
Serious Scarcity Substitution Instrument (SSSI) has lapsed and product is available....
Product Description & Identification
Serious Scarcity Substitution Instrument (SSSI) has lapsed and product is available.
Affected Products
Extension of substitution approval for shortage of Catapres (clonidine) 150 mcg tablets
Additional Source Details
| Field | Value |
|---|---|
| Guid › #text | https://www.tga.gov.au/node/558979 |
| Guid › @ is Perma Link | true |
| Link | https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/medicine-shortage-alerts/extension-substitution-approval-shortage-catapres-clonidine-150-mcg-tablets |
| Pub Date | Tue, 28 Apr 2026 00:00:00 +1000 |
| Extracted category | drugs |
Overview
- Recalling FirmTGA
- Risk LevelMedicines Safety Alert
- DistributionAustralia
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: TGA - Extension of substitution approval for shortage of Catapres (clonidine) 150 mcg tablets Check if your household is affected: https://therecallfile.com/recalls/extension-of-substitution-approval-for-shortage-of-catapres-clonidine/AU-TGA-558979
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Spread the WordExtension of substitution approval for shortage of Catapres (clonidine) 150 mcg tablets